These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
127 related items for PubMed ID: 3359697
1. Long-term follow-up of patients with steroid-dependent, minimal change nephrotic syndrome. Kashtan C, Melvin T, Kim Y. Clin Nephrol; 1988 Feb; 29(2):79-85. PubMed ID: 3359697 [Abstract] [Full Text] [Related]
2. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome. Kyrieleis HA, Levtchenko EN, Wetzels JF. Am J Kidney Dis; 2007 May; 49(5):592-7. PubMed ID: 17472840 [Abstract] [Full Text] [Related]
3. Beneficial effect of chlorambucil in steroid-dependent and cyclophosphamide-resistant minimal change nephrotic syndrome. Ueda N, Takahashi K, Akioka Y, Morooka M, Ogawa A, Tsuzuki K. J Nephrol; 2009 May; 22(5):610-5. PubMed ID: 19809993 [Abstract] [Full Text] [Related]
4. Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome. Li X, Li H, Chen J, He Q, Lv R, Lin W, Li Q, He X, Qu L, Suya W. Nephrol Dial Transplant; 2008 Jun; 23(6):1919-25. PubMed ID: 17911091 [Abstract] [Full Text] [Related]
5. Conventional therapy for idiopathic nephrotic syndrome in children. Brodehl J. Clin Nephrol; 1991 Jun; 35 Suppl 1():S8-15. PubMed ID: 1860269 [Abstract] [Full Text] [Related]
6. Cyclosporin in the treatment of steroid-responsive and steroid-resistant nephrotic syndrome in adults. Maher ER, Sweny P, Chappel M, Varghese Z, Moorhead JF. Nephrol Dial Transplant; 1988 Jun; 3(6):728-32. PubMed ID: 3147413 [Abstract] [Full Text] [Related]
7. The treatment of minimal change nephrotic syndrome (lipoid nephrosis): cooperative studies of the Arbeitsgemeinschaft für Pädiatrische Nephrologie (APN). Brodehl J, Krohn HP, Ehrich JH. Klin Padiatr; 1982 Jun; 194(3):162-5. PubMed ID: 6752557 [Abstract] [Full Text] [Related]
8. Cyclophosphamide therapy in frequently relapsing nephrotic syndrome with and without steroid dependence. Srivastava RN, Agarwal RK, Choudhry VP, Moudgil A, Bhuyan UN, Sunderam KR. Int J Pediatr Nephrol; 1985 Jun; 6(4):245-50. PubMed ID: 4093243 [Abstract] [Full Text] [Related]
9. Beneficial effect of second courses of cytotoxic therapy in children with minimal change nephrotic syndrome. Jones DP, Stapleton FB, Roy S, Wyatt RJ. Pediatr Nephrol; 1988 Jul; 2(3):291-5. PubMed ID: 3153028 [Abstract] [Full Text] [Related]
10. Adult minimal-change disease: clinical characteristics, treatment, and outcomes. Waldman M, Crew RJ, Valeri A, Busch J, Stokes B, Markowitz G, D'Agati V, Appel G. Clin J Am Soc Nephrol; 2007 May; 2(3):445-53. PubMed ID: 17699450 [Abstract] [Full Text] [Related]
11. Pulse cyclophosphamide inadequately suppresses reoccurrence of minimal change nephrotic syndrome in corticoid-dependent children. Donia AF, Gazareen SH, Ahmed HA, Moustafa FE, Shoeib AA, Ismail AM, Khamis S, Sobh MA. Nephrol Dial Transplant; 2003 Oct; 18(10):2054-8. PubMed ID: 13679480 [Abstract] [Full Text] [Related]
12. Remission induced by chlorambucil in steroid-responsive, frequently relapsing nephrotic syndrome that relapsed after cyclophosphamide. Bailey RR. N Z Med J; 1989 Jul 26; 102(872):379-81. PubMed ID: 2797556 [Abstract] [Full Text] [Related]
13. Spontaneous remissions in frequently relapsing and steroid dependent idiopathic nephrotic syndrome. Wingen AM, Müller-Wiefel DE, Schärer K. Clin Nephrol; 1985 Jan 26; 23(1):35-40. PubMed ID: 3978880 [Abstract] [Full Text] [Related]
14. Levamisole: adjunctive therapy in steroid dependent minimal change nephrotic children. Donia AF, Amer GM, Ahmed HA, Gazareen SH, Moustafa FE, Shoeib AA, Ismail AM, Khamis S, Sobh MA. Pediatr Nephrol; 2002 May 26; 17(5):355-8. PubMed ID: 12042893 [Abstract] [Full Text] [Related]
15. The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series. Maas RJ, Deegens JK, Beukhof JR, Reichert LJ, Ten Dam MA, Beutler JJ, van den Wall Bake AWL, Rensma PL, Konings CJ, Geerse DA, Feith GW, Van Kuijk WH, Wetzels JF. Am J Kidney Dis; 2017 May 26; 69(5):637-646. PubMed ID: 28089478 [Abstract] [Full Text] [Related]
16. Long-term evaluation of chlorambucil plus prednisone in the idiopathic nephrotic syndrome of childhood. Williams SA, Makker SP, Ingelfinger JR, Grupe WE. N Engl J Med; 1980 Apr 24; 302(17):929-33. PubMed ID: 6987521 [Abstract] [Full Text] [Related]
17. Long-term ciclosporine A treatment in adults with minimal change nephrotic syndrome or focal segmental glomerulosclerosis. Ittel TH, Clasen W, Fuhs M, Kindler J, Mihatsch MJ, Sieberth HG. Clin Nephrol; 1995 Sep 24; 44(3):156-62. PubMed ID: 8556831 [Abstract] [Full Text] [Related]
18. Cyclophosphamide alone in the treatment of adult patients with minimal change glomerulonephritis. Al-Khader AA, Lien JW, Aber GM. Clin Nephrol; 1979 Jan 24; 11(1):26-30. PubMed ID: 428152 [Abstract] [Full Text] [Related]
19. Linear growth of children with nephrotic syndrome: effect of alkylating agents. Padilla R, Brem AS. Pediatrics; 1989 Sep 24; 84(3):495-9. PubMed ID: 2771553 [Abstract] [Full Text] [Related]
20. The long-term outlook to final outcome and steroid treatment results in children with idiopathic nephrotic syndrome. Dinçel N, Yılmaz E, Kaplan Bulut İ, Hacıkara Ş, Mir S. Ren Fail; 2015 Sep 24; 37(8):1267-72. PubMed ID: 26313331 [Abstract] [Full Text] [Related] Page: [Next] [New Search]